• Co-Targeting BRD4 and Rac1 Pathways Suppresses Breast Cancer

  2026-04-22

  This study demonstrates that simultaneous inhibition of BRD4 and Rac1 disrupts tumor growth, stemness, and metastatic traits across breast cancer subtypes by interfering with the c-MYC-G9a-FTH1 axis and downregulating HDAC1. Results highlight the therapeutic potential of combining a Rac1 GTPase inhibitor such as NSC-23766 with BET bromodomain inhibitors for more effective anti-cancer strategies.

• HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L): Practical Guide

  2026-04-21

  The HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody is designed to enable sensitive, specific fluorescent detection of rabbit primary antibodies in immunoassays such as immunofluorescence, immunohistochemistry, and flow cytometry. This reagent is not suitable for non-rabbit primary antibodies or workflows incompatible with the 488 nm spectral channel.

• Decoding Aconitase: Precision Colorimetric Assay for TCA Cyc

  2026-04-21

  Explore the scientific and translational impact of the Aconitase Activity Colorimetric Assay Kit in uncovering mitochondrial metabolism and oxidative damage. This deep-dive reveals new insights into iron-sulfur protein aconitase and its pivotal role in immunometabolic research.

• Innovations in In Vitro Drug Response Assessment for Cancer

  2026-04-20

  Schwartz (2022) critically re-evaluates how drug responses are measured in cancer models, distinguishing growth inhibition from cell death in vitro. These findings provide a refined framework for interpreting drug efficacy, with direct implications for assay design and translational relevance.

• Carbohydrate-Decorated Nanoparticles Enable Macrophage-Targe

  2026-04-20

  Chen et al. (2020) present a robust nanomedicine platform for macrophage-targeted gene delivery using biodegradable nanoparticles decorated with specific carbohydrates. Their systematic investigation reveals that surface carbohydrate selection significantly enhances mRNA uptake and transfection efficiency in macrophages, offering new tools for precise gene modulation in disease-relevant immune cells.

• OM-MSCs Mitigate Golgi Stress in Cerebral IRI via PEDF-PI3K/

  2026-04-19

  This study demonstrates that olfactory mucosa mesenchymal stem cells (OM-MSCs) alleviate Golgi apparatus (GA) stress after cerebral ischemia/reperfusion injury by activating the PEDF-PI3K/Akt/mTOR pathway. The findings clarify a novel neuroprotective mechanism, opening avenues for targeted therapies in stroke and neural repair.

• Bufalin: Applied Protocols for Triple-Negative Breast Cancer

  2026-04-18

  Bufalin, a potent cardiotonic steroid, is now a cutting-edge tool for targeting Serine/Threonine Kinase 33 in triple-negative breast cancer (TNBC) workflows. This guide delivers detailed experimental protocols, troubleshooting strategies, and translational insights based on the latest peer-reviewed evidence, setting a new standard for applied oncology research.

• Bortezomib (PS-341): Precision Proteasome Inhibition in Apop

  2026-04-17

  Explore how Bortezomib (PS-341) empowers high-resolution apoptosis assays and proteasome research. This in-depth guide reveals advanced mechanistic insights and practical assay strategies not covered elsewhere.

• ω-Agatoxin IVA and Excitotoxicity: Insights from Cortical Cu

  2026-04-16

  This study interrogated the neuroprotective potential of ω-agatoxin IVA, a specific P/Q-type calcium channel blocker, against excitotoxic injury in primary cortical neuronal cultures. Contrary to expectations, blockade of P/Q-type channels did not reduce excitotoxicity induced by depolarizing agents or NMDA, underscoring the complexity of calcium channel involvement in acute neuronal injury.

• Anemoside B4 Inhibits Macrophage NLRP3 Inflammasome in Colit

  2026-04-15

  This study identifies Anemoside B4 (AB4) as a selective inhibitor of CD1d-dependent NLRP3 inflammasome activation in colonic macrophages, demonstrating its potential to alleviate DSS-induced colitis. The findings reveal a mechanistic link between CD1d targeting and suppression of the AKT-STAT1-PRDX1-NF-κB pathway, highlighting new avenues for inflammation research and therapeutic discovery.

• Oligo (dT) 25 Beads: Magnetic Bead-Based mRNA Purification P

  2026-04-14

  Oligo (dT) 25 Beads enable fast, high-yield purification of eukaryotic mRNA from even challenging tissue sources, integrating seamlessly into RT-PCR, sequencing, and multiomics workflows. Their superparamagnetic design, combined with robust oligo (dT) chemistry, offers superior reproducibility and workflow flexibility over conventional mRNA isolation methods.

• RSL3: Optimizing Glutathione Peroxidase 4 Inhibitor Workflow

  2026-04-13

  RSL3, a potent glutathione peroxidase 4 inhibitor, unlocks precise, reproducible ferroptosis assays for cancer biology, especially in RAS-driven tumor models. This article delivers stepwise protocols, advanced troubleshooting, and real-world insights to help researchers harness RSL3's full experimental potential.

• Simvastatin (Zocor) in Lipid Metabolism and Cancer Models

  2026-04-13

  Simvastatin (Zocor) enables robust, reproducible assays in cholesterol metabolism and apoptosis induction in hepatic cancer cells. Leveraging APExBIO's high-purity compound, researchers can optimize workflows for both hyperlipidemia and anti-cancer studies with advanced phenotypic profiling.

• (S)-(+)-Dimethindene maleate: Technical Use in M2 Antagonist

  2026-04-12

  (S)-(+)-Dimethindene maleate is a selective M2 muscarinic receptor antagonist and H1 histamine blocker designed for research into autonomic regulation, cardiovascular, and respiratory physiology. It is most appropriate where precise M2 receptor pathway interrogation is required. Its use is not recommended outside validated research protocols or as a diagnostic or therapeutic agent.

• HyperScript First-Strand cDNA Synthesis Kit: Mechanism & Evi

  2026-04-12

  The HyperScript First-Strand cDNA Synthesis Kit offers high-efficiency first-strand cDNA synthesis from total or poly(A)+ RNA using a thermostable, engineered reverse transcriptase. Its advanced primer options and robust enzyme design enable reliable reverse transcription of complex and low-abundance RNA templates. This article presents critical evidence, protocol parameters, and benchmark data underpinning its use in modern gene expression workflows.

16109 records 1/1074 page Next 12345 下5页 Last page